TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | 17.21%285.55M | ---- | -42.20%243.61M | ---- | 24.92%421.47M | ---- | 14.32%337.4M | ---- | 39.29%295.13M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | 19.90%-27.58M | ---- | -433.37%-34.43M | ---- | -58.21%-6.46M | ---- | 6.93%-4.08M | ---- | -49.62%-4.38M |
Attributable subsidiary (profit) loss | ---- | -2,296.33%-20.36M | ---- | 105.51%927K | ---- | -14.33%-16.81M | ---- | -154.56%-14.71M | ---- | 10.85%-5.78M |
Impairment and provisions: | ---- | -133.58%-7.14M | ---- | 23.78%21.27M | ---- | 13.05%17.18M | ---- | -10.38%15.2M | ---- | -4.51%16.96M |
-Other impairments and provisions | ---- | -133.58%-7.14M | ---- | 23.78%21.27M | ---- | 13.05%17.18M | ---- | -10.38%15.2M | ---- | -4.51%16.96M |
Revaluation surplus: | ---- | 62.15%-14.04M | ---- | -90.01%-37.1M | ---- | -14.02%-19.52M | ---- | -1,109.07%-17.12M | ---- | --1.7M |
-Derivative financial instruments fair value (increase) | ---- | -473.71%-15.97M | ---- | -67.85%4.27M | ---- | -17.62%13.29M | ---- | 803.47%16.13M | ---- | --1.79M |
-Other fair value changes | ---- | 104.65%1.92M | ---- | -26.09%-41.37M | ---- | 1.33%-32.81M | ---- | -37,685.23%-33.25M | ---- | ---88K |
Asset sale loss (gain): | ---- | 6,350.00%375K | ---- | -127.27%-6K | ---- | -69.44%22K | ---- | 119.35%72K | ---- | 17.70%-372K |
-Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 112.73%48K | ---- | 26.65%-377K |
-Loss (gain) on sale of property, machinery and equipment | ---- | 6,350.00%375K | ---- | -127.27%-6K | ---- | -8.33%22K | ---- | 380.00%24K | ---- | -91.94%5K |
Depreciation and amortization: | ---- | 10.04%31.51M | ---- | 25.12%28.64M | ---- | 29.17%22.89M | ---- | 42.82%17.72M | ---- | 524.99%12.41M |
-Depreciation | ---- | -22.23%2.82M | ---- | 11.06%3.63M | ---- | 44.81%3.26M | ---- | 44.21%2.25M | ---- | 21.26%1.56M |
-Amortization of intangible assets | ---- | 31.12%14.1M | ---- | 43.51%10.75M | ---- | 36.39%7.49M | ---- | 50.89%5.49M | ---- | 423.13%3.64M |
Financial expense | ---- | 47.93%408.8M | ---- | 113.85%276.35M | ---- | 1.98%129.23M | ---- | 14.57%126.72M | ---- | 21.34%110.61M |
Exchange Loss (gain) | ---- | -122.72%-10.71M | ---- | 1,690.49%47.14M | ---- | 89.35%-2.96M | ---- | -2,262.99%-27.84M | ---- | 88.36%-1.18M |
Special items | ---- | 88.77%91.15M | ---- | 132.25%48.28M | ---- | -376.77%-149.71M | ---- | -30.09%54.09M | ---- | -21.53%77.37M |
Operating profit before the change of operating capital | ---- | 24.02%737.54M | ---- | 50.43%594.68M | ---- | -18.90%395.32M | ---- | -2.99%487.45M | ---- | 25.18%502.46M |
Change of operating capital | ||||||||||
Accounts receivable (increase)decrease | ---- | -583.06%-50.43M | ---- | 80.99%-7.38M | ---- | -151.96%-38.85M | ---- | -157.87%-15.42M | ---- | -6.41%-5.98M |
Accounts payable increase (decrease) | ---- | -330.55%-78.3M | ---- | -113.04%-18.19M | ---- | 446.01%139.45M | ---- | 46.27%25.54M | ---- | -44.67%17.46M |
Financial assets at fair value (increase)decrease | ---- | -54.91%1.58M | ---- | -4.19%3.5M | ---- | 111.29%3.65M | ---- | ---32.37M | ---- | ---- |
Special items for working capital changes | ---- | 189.13%1.15B | ---- | -128.20%-1.3B | ---- | -1,956.68%-567.7M | ---- | 103.01%30.58M | ---- | 29.36%-1.02B |
Cash from business operations | ---- | 344.18%1.77B | ---- | -961.10%-722.87M | ---- | -113.74%-68.13M | ---- | 198.52%495.78M | ---- | 50.30%-503.25M |
Other taxs | ---- | -79.48%-83.16M | ---- | -69.17%-46.33M | ---- | 23.10%-27.39M | ---- | 60.86%-35.62M | ---- | -153.45%-90.99M |
Special items of business | -9.36%574.57M | ---- | 37.75%633.92M | ---- | 272.88%460.21M | ---- | -284.93%-266.2M | ---- | 121.18%143.94M | ---- |
Net cash from operations | -9.36%574.57M | 318.66%1.68B | 37.75%633.92M | -705.34%-769.2M | 272.88%460.21M | -120.76%-95.51M | -284.93%-266.2M | 177.44%460.17M | 121.18%143.94M | 43.33%-594.24M |
Cash flow from investment activities | ||||||||||
Interest received - investment | 38.70%9.05M | 32.96%15.52M | 8.39%6.53M | 80.84%11.67M | 204.91%6.02M | 50.12%6.46M | 11.08%1.98M | -0.44%4.3M | -18.59%1.78M | 47.41%4.32M |
Dividend received - investment | --6.47M | ---- | ---- | ---- | ---- | -99.54%20K | ---- | --4.38M | --4.38M | ---- |
Loan receivable (increase) decrease | -90.91%15.22M | 100.15%272K | --167.5M | ---186.42M | --0 | --0 | ---- | -7.73%25.37M | 183.71%1.08M | 575.34%27.5M |
Decrease in deposits (increase) | 968.97%107.74M | 67.57%-34.89M | 88.78%-12.4M | -1,669.72%-107.57M | -6,241.75%-110.49M | 104.05%6.85M | 102.02%1.8M | -118.00%-169.14M | -106.97%-89.2M | -785.28%-77.59M |
Sale of fixed assets | -87.50%4K | 4,542.86%325K | 3,100.00%32K | -87.72%7K | -66.67%1K | -33.72%57K | 200.00%3K | 4,200.00%86K | --1K | -75.00%2K |
Purchase of fixed assets | -123.03%-30.37M | -242.16%-34.77M | -1,966.01%-13.62M | 24.45%-10.16M | 72.70%-659K | -209.98%-13.45M | -90.98%-2.41M | 2.43%-4.34M | 45.80%-1.26M | -67.68%-4.45M |
Purchase of intangible assets | 11.82%-12.42M | 74.03%-27.03M | 85.30%-14.08M | -411.43%-104.08M | -1,079.54%-95.78M | -170.48%-20.35M | -262.50%-8.12M | 29.28%-7.52M | 64.72%-2.24M | 24.36%-10.64M |
Sale of subsidiaries | ---206.94M | ---- | ---- | ---- | ---- | ---- | ---- | 250.19%5.6M | 460.30%5.6M | -91.86%1.6M |
Acquisition of subsidiaries | ---- | ---- | ---- | -157.69%-32.24M | --262K | ---12.51M | ---- | ---- | ---- | ---24.24M |
Recovery of cash from investments | 113.21%929.07M | -39.75%1.06B | 13.72%435.76M | 750.21%1.76B | 603.54%383.18M | 374.23%207.33M | 666.46%54.47M | 21,650.25%43.72M | --7.11M | --201K |
Cash on investment | -63.29%-1.02B | 13.88%-1.67B | -27.44%-623.43M | -444.90%-1.94B | -143.16%-489.18M | -113.96%-356.91M | -123.56%-201.18M | -695.74%-166.81M | -1,449.93%-89.99M | 50.09%-20.96M |
Other items in the investment business | 100.16%263K | -2,472.72%-204.92M | -81,692.04%-164M | 78.96%-7.97M | 101.17%201K | -81.17%-37.85M | 13.83%-17.22M | -132.14%-20.89M | ---19.98M | ---9M |
Net cash from investment operations | 8.19%-199.87M | -45.17%-898.41M | 28.96%-217.71M | -180.84%-618.86M | -79.53%-306.44M | 22.74%-220.36M | 6.59%-170.69M | -151.86%-285.24M | -228.07%-182.72M | -177.48%-113.25M |
Net cash before financing | -9.97%374.7M | 156.45%783.53M | 170.68%416.21M | -339.43%-1.39B | 135.20%153.77M | -280.57%-315.88M | -1,026.59%-436.89M | 124.73%174.93M | 94.73%-38.78M | 35.05%-707.49M |
Cash flow from financing activities | ||||||||||
New borrowing | -22.76%4.52B | 40.42%9.88B | 104.81%5.85B | 80.81%7.04B | 87.00%2.86B | 53.27%3.89B | 55.81%1.53B | -4.44%2.54B | 9.63%980.66M | -45.20%2.66B |
Refund | 28.24%-4.26B | -82.05%-9.72B | -134.25%-5.94B | -66.74%-5.34B | -180.44%-2.54B | -9.57%-3.2B | 8.88%-904.29M | -72.40%-2.92B | -439.24%-992.45M | 61.68%-1.7B |
Issuing shares | ---- | ---- | ---- | -97.29%12.89M | -25.19%4.14M | 41.19%475.95M | 109.46%5.54M | 5,953.03%337.09M | 1,650.99%2.64M | -99.20%5.57M |
Interest paid - financing | 4.33%-190.69M | -83.32%-393.54M | -71.69%-199.32M | -47.84%-214.67M | -99.15%-116.09M | -8.41%-145.2M | -8.01%-58.3M | -35.77%-133.93M | -66.58%-53.97M | -26.78%-98.65M |
Dividends paid - financing | ---268.56M | 5.16%-70.63M | ---- | -5.59%-74.48M | ---- | -69.36%-70.54M | -29.09%-54.69M | -23.86%-41.65M | -37.08%-42.36M | ---33.63M |
Absorb investment income | ---- | ---- | ---- | --12M | ---- | ---- | ---- | ---- | ---- | -81.66%17.15M |
Issuance expenses and redemption of securities expenses | 93.26%-6.12M | ---96.09M | ---90.79M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Pledged bank deposit (increase) decrease | -1,518.39%-73.38M | -62.64%-260.96M | 97.00%-4.53M | 1.17%-160.45M | -56.18%-151.19M | ---162.35M | -1,048.69%-96.8M | ---- | ---8.43M | ---- |
Other items of the financing business | -109.60%-1.65M | 33.39%-31.82M | 173.36%17.13M | ---47.76M | -16.74%-23.35M | ---- | ---20M | 200.00%6.3M | ---- | ---6.3M |
Net cash from financing operations | 22.53%-288.12M | -158.24%-705.92M | -1,435.79%-371.92M | 56.31%1.21B | -92.93%27.84M | 445.64%775.4M | 433.95%393.6M | -126.72%-224.34M | -117.83%-117.86M | -25.76%839.71M |
Effect of rate | 35.83%-3.73M | 107.53%3.56M | 75.35%-5.82M | -1,678.65%-47.31M | -450.28%-23.6M | -89.23%3M | 185.54%6.74M | 2,262.99%27.84M | -3,687.02%-7.88M | -88.36%1.18M |
Net Cash | 95.49%86.58M | 144.08%77.62M | -75.61%44.29M | -138.31%-176.07M | 519.50%181.61M | 1,029.99%459.53M | 72.36%-43.29M | -137.37%-49.41M | -110.28%-156.64M | 217.31%132.22M |
Begining period cash | 14.07%658.21M | -27.91%577.03M | -27.91%577.03M | 136.89%800.41M | 136.89%800.41M | -6.00%337.89M | -6.00%337.89M | 59.01%359.46M | 59.01%359.46M | 29.72%226.07M |
Cash at the end | 20.40%741.05M | 14.07%658.21M | -35.78%615.5M | -27.91%577.03M | 218.06%958.42M | 136.89%800.41M | 54.57%301.33M | -6.00%337.89M | 28.79%194.94M | 59.01%359.46M |
Cash balance analysis | ||||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.